Patents
Patents for C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516)
06/2012
06/13/2012CN101824066B Method for preparing rocuronium bromide midbody compound crystal
05/2012
05/31/2012US20120135065 Amphoteric Liposomes, A Method Of Formulating An Amphoteric Liposome And A Method Of Loading An Amphoteric Liposome
05/30/2012CN102477061A 吡啶雄甾衍生物及其在制备预防和/或治疗前列腺癌药物中的用途 Pyridine-androstene derivatives and their use in the manufacture of prevention and / or treatment of prostate cancer medicament
05/23/2012CN101704871B Steroid compound and application thereof
05/22/2012CA2614667C 20-keto-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties
05/16/2012EP1888615B1 17 -hsd1 and sts inhibitors
05/10/2012US20120115169 Hydroxycholesterol immunoassay
05/09/2012EP1480960B1 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments
05/09/2012CN102448978A Novel Glucocorticoid Receptor Agonists
05/02/2012CN102432662A Crystal form of pipecuronium bromide, preparation method and application of crystal form
05/02/2012CN102432661A Method for preparing high-purity etioline
04/2012
04/18/2012CN101732730B 含咪唑嗡盐和大环多胺的阳离子脂质、转基因载体及制备方法 Om imidazole-containing macrocyclic polyamine salts and cationic lipids, gene transfer vector and preparation methods
04/04/2012EP2435462A1 Novel glucocorticoid receptor agonists
03/2012
03/22/2012US20120071453 Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them
03/21/2012CN102382164A Toad lactam compound as well as preparation method and application thereof
03/14/2012EP2428519A2 Process for the preparation of 17-vinyl- triflates as intermediates
03/14/2012EP2427472A1 Lipophilic polynucleotide conjugates
03/14/2012CN102372762A Novel technology for synthesizing pregnene 11-site beta-hydroxy
03/14/2012CN102372756A Specific glucocorticosteroid compound having anti-inflammatory activity
03/06/2012CA2560694C Progesterone receptor modulators
03/01/2012US20120053340 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether
03/01/2012US20120053163 Steroids as Agonists for FXR
03/01/2012US20120053162 Certain chemical entities, compositions, and methods
02/2012
02/29/2012EP2421882A2 Angiogenesis inhibitors
02/23/2012US20120046461 Steroidal anti-hormone hybrids
02/22/2012CN102358750A Helix 12 directed pharmaceutical products
02/22/2012CN102357247A Therapeutic methods and delivery systems utilizing sex steroid precursors
02/15/2012EP2417148A1 Progesterone antagonists spiro condensed in position 17 with a difluoromethylene- substituted perhydrofurane group
02/15/2012CN102353661A Fluorescent sensor film preparation method based on perylene diimide cholesterol derivative
02/08/2012CN102344480A Method for synthesizing dendritic aminosterol substance
02/08/2012CN102344479A Preparation method of quaternary ammonium salts of methyl ammonium bromide
02/01/2012CN102336801A Abiraterone acetate polymorphic substance and pharmaceutical composition
01/2012
01/26/2012WO2012011106A1 Process for the preparation of 17-desoxy-corticosteroids
01/24/2012CA2163748C Methods and compositions for inducing sleep
01/18/2012CN102321142A Abiraterone acetate crystal form and preparation method thereof
01/18/2012CN102321140A Lipoid cation function molecule synthesized from natural cholesterol and amino acid and preparation method and application thereof
01/12/2012US20120010173 Fosfluconazole Derivatives, Synthesis, and Use in Long Acting Formulations
01/12/2012DE102010027016A1 New steroid-styryl dye conjugates useful e.g. for simulation and direct light optical detection of the behavior of steroid in the living biological tissue in the presence of a steroid binding protein
01/10/2012US8093233 Agent for inhibiting visceral fat accumulation
01/10/2012CA2454339C Methods for preventing antipsychotic-induced weight gain
01/03/2012US8088758 17β-hydroxysteroid dehydrogenase type I inhibitors
12/2011
12/22/2011US20110312926 2-(N-Substituted Piperazinyl) Steroid Derivatives
12/22/2011US20110312924 Novel steroidal cyp17 inhibitors/antiandrogens
12/22/2011US20110312916 Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
12/21/2011CN102286053A 孕甾烯醇酮吡咯化合物及其制备方法 Pregnenolone azole compound and its preparation method
12/20/2011US8080540 Therapeutically active triazoles and their use
12/14/2011EP2393827A1 Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
12/13/2011US8076474 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether
11/2011
11/30/2011EP2390260A2 Ester derivative of ethinyl estradiol
11/24/2011US20110288288 Process for the preparation of 17-0-vinyl- triflates as intermediates
11/23/2011CN101130567B Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
11/16/2011EP1781683B1 Process for the preparation of 17-vinyl- triflates as intermediates
11/15/2011US8058267 Steroids as agonists for FXR
11/10/2011US20110275604 Aminoalkylsterol compounds with antitumoral and neuroprotective activity
11/02/2011CN102229636A New derivatives of berberine coupled with cholic acid at ninth position through ester bond and preparation methods thereof
10/2011
10/27/2011WO2011098437A3 Progesterone receptor antagonists
10/27/2011US20110262368 C21 thioethers as glucocorticoid receptor agonists
10/26/2011CN102225962A New derivative bonded by berberine and cholic acid at 9th position of berberine and preparation method thereof
10/26/2011CN102225961A Novel berberine 9-position coupled cholic acid derivative and preparation method thereof
10/20/2011WO2011098436A3 Progesterone receptor antagonists
10/12/2011EP2373674A1 2-(n-substituted piperazinyl) steroid derivatives
10/11/2011CA2481561C Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity
10/04/2011US8030482 Free cholesterol analogs bearing a boron dipyrromethene difluoro (BODIPY) fluorophore in the side chain and method of preparation and use thereof
09/2011
09/22/2011WO2011059969A3 Mammalian metabolites of steroids
09/22/2011US20110229581 Releasable cationic lipids for nucleic acids delivery systems
09/07/2011CN101260136B Oestrogen derivatives as inhibitors of steroid sulphatase
09/01/2011US20110212935 Compositions and treatment methods-4
08/2011
08/31/2011CN102167718A 16-imidazole substitute-3amine substitute-5 alpha androstane derivatives and preparation method and application thereof
08/25/2011US20110207154 Method for determination of marinobufagenin levels and compounds employable in such method
08/24/2011CN102161688A Cholesterol-structure-fragment-containing biocompatible synthesis liposomes as well as preparation method and application thereof
08/18/2011US20110200582 Lipids, lipid compositions, and methods of using them
08/18/2011CA2789240A1 Progesterone receptor antagonists
08/18/2011CA2789237A1 Progesterone receptor antagonists
08/17/2011CN101218245B 3-ester prodrugs of ethynylestradiol
08/11/2011DE102010007722A1 Progesteronrezeptorantagonisten Progesterone receptor antagonists
07/2011
07/28/2011WO2011089541A1 Methods for intracellular delivery of nucleic acids
07/28/2011US20110182828 C20-c21 substituted glucocorticoid receptor agonists
07/28/2011CA2786766A1 Methods for intracellular delivery of nucleic acids
07/27/2011EP2348032A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent
07/27/2011EP2348031A2 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents
07/27/2011EP2348030A2 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents
07/20/2011EP2345732A1 Methods for intracellular delivery of nucleic acids
07/12/2011CA2279971C Androgen synthesis inhibitors
07/07/2011US20110165225 Modified Drugs for Use in Liposomal Nanoparticles
06/2011
06/30/2011CA2785492A1 Lipids, lipid compositions, and methods of using them
06/16/2011US20110144075 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
06/15/2011CN102099368A C-21 thioethers as glucocorticoid receptor agonists
06/15/2011CN102093455A 16-substituted-3heterocycle-5alpha androstane derivative, and preparation method and application thereof
06/14/2011CA2512987C 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators
06/14/2011CA2458267C Bifunctional chelating agent for actinium
06/07/2011CA2628607C Androgen synthesis inhibitors
06/01/2011CN102083850A Selective high-affinity polydentate ligands and methods of making such
06/01/2011CN102083849A Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method
06/01/2011CN102079771A Estrogen amino-acid ester compound with antitumor activity as well as synthetic method thereof
05/2011
05/31/2011US7951965 Having semiconductor properties of electron transfer, electroluminescence, and photoluminescence. Intermolecular stacking can be avoided, enhanced electron-luminescent emission stability, applied as a light-emitting material in organic EL devices
05/24/2011US7947668 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity
05/19/2011US20110118225 Ligands of Estrogen Receptors alpha and beta, Method of Their Preparation, and Pharmaceuticals Comprising Them
05/19/2011CA2780365A1 Mammalian metabolites of steroids
05/11/2011CN101597315B Organic metal coordination compound gelator and luminous gel composed of same
05/10/2011CA1341613C Assays utilizing improved chemiluminescent esters, thioesters and amides
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 26